Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.

Lalude OO.

Curr Cardiol Rep. 2013 Jul;15(7):374. doi: 10.1007/s11886-013-0374-2. Review.

PMID:
23715878
2.

Thrombotic diseases in young women and the influence of oral contraceptives.

Lidegaard O.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 2):S62-7. Review.

PMID:
9753312
3.

Hormonal contraception, thrombosis and age.

Lidegaard Ø.

Expert Opin Drug Saf. 2014 Oct;13(10):1353-60. doi: 10.1517/14740338.2014.950654. Review.

PMID:
25227335
4.

Thrombotic stroke and myocardial infarction with hormonal contraception.

Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N.

N Engl J Med. 2012 Jun 14;366(24):2257-66. doi: 10.1056/NEJMoa1111840.

5.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521
6.

Contraceptive choices in women with coagulation disorders.

Comp PC, Zacur HA.

Am J Obstet Gynecol. 1993 Jun;168(6 Pt 2):1990-3. Review.

PMID:
8512043
7.

Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.

Dragoman M, Curtis KM, Gaffield ME.

Contraception. 2016 Sep;94(3):280-7. doi: 10.1016/j.contraception.2015.08.002. Epub 2015 Aug 10. Review.

8.

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM.

Cochrane Database Syst Rev. 2015 Aug 27;(8):CD011054. doi: 10.1002/14651858.CD011054.pub2. Review.

PMID:
26310586
9.

Safety of hormonal contraceptives among women with migraine: A systematic review.

Tepper NK, Whiteman MK, Zapata LB, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):630-640. doi: 10.1016/j.contraception.2016.04.016. Epub 2016 May 3. Review.

PMID:
27153744
10.

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.

Lidegaard O, Nielsen LH, Skovlund CW, Løkkegaard E.

BMJ. 2012 May 10;344:e2990. doi: 10.1136/bmj.e2990.

11.

Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.

Horton LG, Simmons KB, Curtis KM.

Contraception. 2016 Dec;94(6):590-604. doi: 10.1016/j.contraception.2016.05.014. Epub 2016 Jun 1. Review.

PMID:
27263039
12.

Hormonal contraception and risk of venous thromboembolism: national follow-up study.

Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C.

BMJ. 2009 Aug 13;339:b2890. doi: 10.1136/bmj.b2890.

13.
14.

An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.

Thorogood M, Vessey MP.

Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):274-81. Review.

PMID:
2196799
15.

Hormonal contraception and risk of cardiovascular disease. An international perspective.

Farley TM, Collins J, Schlesselman JJ.

Contraception. 1998 Mar;57(3):211-30. Review.

PMID:
9617537
17.

Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.

[No authors listed]

Prescrire Int. 1998 Aug;7(36):118-24. Review.

PMID:
10342951
18.

Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.

Mann JI.

Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):752-7.

PMID:
7065056
19.

[Vascular disease and hormonal treatment--epidemiology].

Vessey MP.

Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):121-6. French.

PMID:
12280197
20.

Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.

[No authors listed]

World Health Organ Tech Rep Ser. 1998;877:i-vii, 1-89. Review.

PMID:
9615606

Supplemental Content

Support Center